Abstract: The invention pertains to a method of treating or preventing pressure ulcers, comprising enterally administering to a subject in need thereof a composition comprising proteins, carbohydrates, fats, arginine or equivalents thereof, ascorbic acid equivalents and a-tocopherol equivalents, wherein arginine or equivalents thereof is administered in a daily amount of 3-15 g, ascorbic acid equivalents are administered in a daily amount of 180-840 mg and a-tocopherol equivalents are administered in a daily amount of 50-400 mg.

Abstract: A method for identifying low-pressure tires includes determining the number of revolutions of each wheel over a preselected driving distance, and comparing crosswise by summing the number of revolutions of the diagonally opposite front right/rear left and front left/rear right wheels and taking the difference between the sums, a diagonal containing a low-pressure tire being identifiable via the sign of the difference between the diagonals. A further comparison for each side of the vehicle is effected by summing the revolutions of the front left/rear left side and front right/rear right side wheels and comparing the difference between the sums, the side containing a low-pressure tire being identifiable via the sign of the difference between the sides. The difference between diagonals is compared with a low-pressure threshold value. If the threshold is exceeded, the signs of the difference between diagonals and between sides are logically combined to identify the low-pressure tire.

Abstract: The invention pertains to a method of treating or preventing pressure ulcers, comprising enterally administering to a subject in need thereof a composition comprising proteins, carbohydrates, fats, arginine or equivalents thereof, ascorbic acid equivalents and ?-tocopherol equivalents, wherein arginine or equivalents thereof is administered in a daily amount of 3-15 g, ascorbic acid equivalents are administered in a daily amount of 180-840 mg and ?-tocopherol equivalents are administered in a daily amount of 50-400 mg.

Abstract: A method for identifying low-pressure tires includes determining the number of revolutions of each wheel over a preselected driving distance, and comparing crosswise by summing the number of revolutions of the diagonally opposite front right/rear left and front left/rear right wheels and taking the difference between the sums, a diagonal containing a low-pressure tire being identifiable via the sign of the difference between the diagonals. A further comparison for each side of the vehicle is effected by summing the revolutions of the front left/rear left side and front right/rear right side wheels and comparing the difference between the sums, the side containing a low-pressure tire being identifiable via the sign of the difference between the sides. The difference between diagonals is compared with a low-pressure threshold value. If the threshold is exceeded, the signs of the difference between diagonals and between sides are logically combined to identify the low-pressure tire.

Abstract: A nutritional booster composition suitable for the treatment of pressure ulcers, comprising proteins, carbohydrates and fats and, in a daily unit dose: 3-15 g of arginine or equivalents thereof, 180-840 mg of ascorbic acid equivalents, 50-400 mg of ?-tocopherol equivalents, and 8-40 mg of flavonoids.

Abstract: A tire pressure monitoring system and method for vehicles equipped with anti-lock breaking systems (ABS), especially vehicles with more than two axles, is provided. Wheel sensors associated with the ABS are utilized to sense variables which depend on wheel rotation, such as speed of rotation of the wheels or travel distances covered by the wheels. An ABS control unit logically combines the determined variables with one another and performs an evaluation with respect to change of rolling radii of the wheels while allowing for changes of the variable caused by driving operation. The ABS control unit generates a warning signal when the change of variables caused by tire pressure decrease exceeds a preselected limit value. In addition to the wheel sensors, a tire pressure measuring system which measures the absolute tire inflation pressure of the wheels of at least one axle and generates a warning signal when the measured tire inflation pressure drops below a preselected setpoint pressure can be utilized.

Abstract: A tire pressure monitoring system and method for vehicles equipped with anti-ing lock breaking systems (ABS), especially vehicles with more than two axles, is provided. Wheel sensors associated with the ABS are utilized to sense variables which depend on wheel rotation, such as speed of rotation of the wheels or travel distances covered by the wheels. An ABS control unit logically combines the determined variables with one another and performs an evaluation with respect to change of rolling radii of the wheels while allowing for changes of the variable caused by driving operation. The ABS control unit generates a warning signal when the change of variables caused by tire pressure decrease exceeds a preselected limit value. In addition to the wheel sensors, a tire pressure measuring system which measures the absolute tire inflation pressure of the wheels of at least one axle and generates a warning signal when the measured tire inflation pressure drops below a preselected setpoint pressure can be utilized.

Abstract: A nutritional composition, suitable for enteral administration, is described which contains 5-120 g of composite dietary fibre per daily dosage of the composition or per 2000 kcal, which fibre consists of 15-50 wt. % of soluble non-starch polysaccharides, such as gum arabic or pectin, 15-45 wt. % of insoluble non-starch polysaccharides, such as cellulose and hemicellulose, and 8-70 wt. % of oligosaccharides and/or resistant starch and/or lignin. The oligosaccharides such as inulin or hydrolyzed inulin can be present at a level of 8-40 wt. %. The resistant starch may be present at a level of 5-30 wt. %. The composition may further contain carbohydrates and/or fats and/or proteinaceous material and may be dry or liquid. It may be used as a complete food or a food supplement, e.g. for clinical patients or infants.